Vincent Remouchamps

4.2k total citations · 1 hit paper
48 papers, 2.3k citations indexed

About

Vincent Remouchamps is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vincent Remouchamps has authored 48 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiation, 23 papers in Pulmonary and Respiratory Medicine and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vincent Remouchamps's work include Advanced Radiotherapy Techniques (27 papers), Breast Cancer Treatment Studies (16 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Vincent Remouchamps is often cited by papers focused on Advanced Radiotherapy Techniques (27 papers), Breast Cancer Treatment Studies (16 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Vincent Remouchamps collaborates with scholars based in Belgium, United States and France. Vincent Remouchamps's co-authors include John Wong, Frank A. Vicini, Larry L. Kestin, Alvaro A. Martinez, Michael B. Sharpe, Nicola Letts, J Fayad, Philip Poortmans, Caroline Weltens and Kathy Baglan and has published in prestigious journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Vincent Remouchamps

45 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

2015 485 citations Birgitte Vrou Offersen, Liesbeth Boersma et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Vincent Remouchamps

Since Specialization

Citations

This map shows the geographic impact of Vincent Remouchamps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Remouchamps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Remouchamps more than expected).

Fields of papers citing papers by Vincent Remouchamps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Remouchamps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Remouchamps. The network helps show where Vincent Remouchamps may publish in the future.

Co-authorship network of co-authors of Vincent Remouchamps

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Remouchamps. A scholar is included among the top collaborators of Vincent Remouchamps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Remouchamps. Vincent Remouchamps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial	Radiotherapy and Oncology	Alex De Caluwé, Kim Cao et al.	2
2	2O TILs and PD-L1 early dynamics in the randomized Neo-CheckRay phase II trial evaluating neo-adjuvant immuno-radiation and adenosine pathway blockade for early-stage, high risk ER+/HER2- breast cancer (BC)	Immuno-Oncology Technology	Isabelle Desmoulins, Emanuela Romano et al.	0
3	LBA10 Primary endpoint results of the Neo-CheckRay phase II trial evaluating stereotactic body radiation therapy (SBRT) +/- durvalumab (durva) +/- oleclumab (ole) combined with neo-adjuvant chemotherapy (NACT) for early-stage, high risk ER+/HER2- breast cancer (BC)	Annals of Oncology	Alex De Caluwé, Isabelle Desmoulins et al.	3
4	Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?	Reports of Practical Oncology & Radiotherapy	A. Van Esch, Vincent Remouchamps et al.	2
5	Radiation therapy-induced left vocal cord paralysis following lung stereotactic body radiation therapy: A case report and review of the literature	Cancer/Radiothérapie	P. Van Houtte, Vincent Remouchamps et al.	1
6	Radiotherapy-specific quality indicators at national level: How to make it happen	Radiotherapy and Oncology	Nicolas Jansen, Caroline Weltens et al.	4
7	ProCaLung – Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium☆	Radiotherapy and Oncology	Yolande Lievens, Xavier Geets et al.	3
8	Delineation guidelines for the lymphatic target volumes in ‘prone crawl’ radiotherapy treatment position for breast cancer patients	Scientific Reports	Pieter Deseyne, Chris Monten et al.	2
9	Illustration of a fatal radiation-induced lung aneurysm: Is central lung stereotactic radiotherapy to be banned?	Cancer/Radiothérapie	Sebahat Ocak, Vincent Remouchamps et al.	2
10	Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab	Lung Cancer	Benoı̂t Rondelet, Thierry Vander Borght et al.	31
11	Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial	Journal of Thoracic Oncology	Maria Christodoulou, Fiona Blackhall et al.	25
12	OA05.06 Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily versus Twice-Daily RadioTherapy (CONVERT) Trial	Journal of Thoracic Oncology	Maria Christodoulou, Fiona Blackhall et al.	1
13	An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging	Strahlentherapie und Onkologie	François‐Xavier Hanin, Benoît Ghaye et al.	11
14	ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer breakdown →	Radiotherapy and Oncology	Birgitte Vrou Offersen, Liesbeth Boersma et al.	485
15	Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy	BMC Cancer	Sofie De Langhe, Thomas Mulliez et al.	90
16	Guidelines for primary radiotherapy of patients with prostate cancer	Radiotherapy and Oncology	Dirk Boehmer, P. Maingon et al.	111
17	Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study	Annals of Oncology	J-P. Machiels, Lionel Duck et al.	106
18	Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC	International Journal of Radiation OncologyBiologyPhysics	Pierre Scalliet, Vincent Remouchamps et al.	7
19	A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: survival and progression-free survival	Cancer/Radiothérapie	Pierre Scalliet, Vincent Remouchamps et al.	6
20	Evaluation of a leaf position optimization tool for intensity modulated radiation therapy of head and neck cancer	Radiotherapy and Oncology	Filip Claus, Werner De Gersem et al.	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact